- Home
- MVBF vs ACIU Comparison
MVBF vs ACIU Comparison
Compare MVBF & ACIU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MVBF
- ACIU
- Stock Information
- Founded
- MVBF 1997
- ACIU 2003
- Country
- MVBF United States
- ACIU Switzerland
- Employees
- MVBF N/A
- ACIU N/A
- Industry
- MVBF Major Banks
- ACIU Biotechnology: Pharmaceutical Preparations
- Sector
- MVBF Finance
- ACIU Health Care
- Exchange
- MVBF Nasdaq
- ACIU Nasdaq
- Market Cap
- MVBF 281.6M
- ACIU 332.4M
- IPO Year
- MVBF N/A
- ACIU 2016
- Fundamental
- Price
- MVBF $20.03
- ACIU $2.68
- Analyst Decision
- MVBF Buy
- ACIU Strong Buy
- Analyst Count
- MVBF 2
- ACIU 2
- Target Price
- MVBF $27.50
- ACIU $12.00
- AVG Volume (30 Days)
- MVBF 37.5K
- ACIU 134.5K
- Earning Date
- MVBF 02-12-2025
- ACIU 11-05-2024
- Dividend Yield
- MVBF 3.20%
- ACIU N/A
- EPS Growth
- MVBF N/A
- ACIU N/A
- EPS
- MVBF 1.41
- ACIU N/A
- Revenue
- MVBF $140,251,000.00
- ACIU $48,505,404.00
- Revenue This Year
- MVBF N/A
- ACIU $85.33
- Revenue Next Year
- MVBF $7.90
- ACIU $80.69
- P/E Ratio
- MVBF $15.10
- ACIU N/A
- Revenue Growth
- MVBF N/A
- ACIU 4097200.00
- 52 Week Low
- MVBF $17.51
- ACIU $2.25
- 52 Week High
- MVBF $25.24
- ACIU $5.14
- Technical
- Relative Strength Index (RSI)
- MVBF 36.07
- ACIU 27.49
- Support Level
- MVBF $21.51
- ACIU $2.62
- Resistance Level
- MVBF $21.27
- ACIU $3.02
- Average True Range (ATR)
- MVBF 0.58
- ACIU 0.13
- MACD
- MVBF -0.25
- ACIU -0.05
- Stochastic Oscillator
- MVBF 10.91
- ACIU 9.52
About MVBF MVB Financial Corp.
MVB Financial Corp is a bank holding company. The company provides community banking, mortgage banking, insurance and wealth management services to individuals and corporate clients in the Mid-Atlantic region. The Bank offers its customers various products, such as checking accounts, negotiable order of withdrawal (NOW) accounts, money market and savings accounts, time certificates of deposit, commercial, installment, commercial real estate and residential real estate mortgage loans, debit cards, and safe deposit rental facilities. MVB has three reportable segments: CoRe banking; mortgage banking and the financial holding company. It generates majority of its revenues from its CoRe banking segment.
About ACIU AC Immune SA
AC Immune SA is a clinical-stage biopharmaceutical company that focuses on neurodegenerative diseases. The company uses its proprietary technology platforms to discover, design, and develop novel proprietary small molecules, antibodies, and vaccines for the prevention, diagnosis, and treatment of neurodegenerative diseases associated with protein misfolding. The Company has one segment. The Company currently focuses most of its resources on discovering and developing therapeutic and diagnostic products targeting misfolded proteins. The company's pipeline consists of ACI-24.060, Crenezumab, ACI-35.030, Semorinemab, ACI-7104.056, and others.